Literature DB >> 8632166

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease.

S D Harr1, L Uint, R Hollister, B T Hyman, A J Mendez.   

Abstract

Inheritance of the epsilon 4 allele of apolipoprotein (apo) E is associated with increased risk of Alzheimer's disease (AD) and with increased beta-amyloid peptide (A beta) deposition in the cortex. Apo E is a member of a family of exchangeable apos, characterized by the presence of amphipathic alpha-helical segments that allow these molecules to act as surfactants on the surface of lipoprotein particles. Two members of this family, apo E and apo J, have been shown to bind soluble A beta, and both are associated with senile plaques in the AD cortex. We now have studied the pattern of brain apo expression and found that five members of this class are present: apo A-I, A-IV,D,E, and J. By contrast, apos A-II, B, and C-II were not detectable. Immunohistochemistry revealed that, in addition to apo E and apo J, apo A-I immunostained occasional senile plaques in AD cortex. Immunoblot analysis showed no difference in the relative amounts of any of these apos in tissue homogenates of frontal lobe from AD or control patients. Comparison by APO E genotype showed no differences in the amount of apo E in brain among APO E epsilon 3/3, epsilon 3/4, or epsilon 4/4 individuals; however, a significant decrease in the amount of apo J was associated with the APO E epsilon 4 allele. No differences in apo J levels were detected in CSF samples of AD subjects. We propose that several members of the exchangeable apo family may interact with A beta deposits in senile plaques through common amphipathic alpha-helical domains. Competition among these molecules for binding of A beta or A beta aggregates may influence the deposition of A beta in senile plaques.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8632166     DOI: 10.1046/j.1471-4159.1996.66062429.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  40 in total

Review 1.  Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease.

Authors:  W G Wood; F Schroeder; N A Avdulov; S V Chochina; U Igbavboa
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

2.  Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.

Authors:  Anthony R White; Gerd Multhaup; Denise Galatis; William J McKinstry; Michael W Parker; Rüdiger Pipkorn; Konrad Beyreuther; Colin L Masters; Roberto Cappai
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

3.  ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis.

Authors:  Anne M Fagan; Erin Christopher; Jennie W Taylor; Maia Parsadanian; Michael Spinner; Melanie Watson; John D Fryer; Suzanne Wahrle; Kelly R Bales; Steven M Paul; David M Holtzman
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

4.  Genetic polymorphisms of clusterin gene are associated with a decreased risk of Alzheimer's disease.

Authors:  Yen-Ling Lin; Shih-Yuan Chen; Liang-Chuan Lai; Jen-Hau Chen; Shi-Yi Yang; Yi-Ling Huang; Ta-Fu Chen; Yu Sun; Li-Li Wen; Ping-Keung Yip; Yi-Min Chu; Wei J Chen; Yen-Ching Chen
Journal:  Eur J Epidemiol       Date:  2012-01-28       Impact factor: 8.082

Review 5.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

6.  Invited commentary: lipoproteins and dementia - is it the apolipoprotein A-I?

Authors:  Nikolaos Scarmeas
Journal:  Am J Epidemiol       Date:  2007-02-13       Impact factor: 4.897

7.  Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Neurobiol Aging       Date:  2011-06-15       Impact factor: 4.673

Review 8.  The pathogenesis of amyloidosis: understanding general principles.

Authors:  P Westermark
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

9.  Altered Blood Gene Expression of Tumor-Related Genes (PRKCB, BECN1, and CDKN2A) in Alzheimer's Disease.

Authors:  Anna Antonell; Albert Lladó; Raquel Sánchez-Valle; Coral Sanfeliu; Teresa Casserras; Lorena Rami; Cristina Muñoz-García; Adrià Dangla-Valls; Mircea Balasa; Patricia Boya; Susana G Kalko; José Luis Molinuevo
Journal:  Mol Neurobiol       Date:  2015-10-28       Impact factor: 5.590

10.  Macrophage scavenger receptor A mediates adhesion to apolipoproteins A-I and E.

Authors:  Claudine Neyen; Annette Plüddemann; Pietro Roversi; Benjamin Thomas; Lei Cai; Deneys R van der Westhuyzen; Robert B Sim; Siamon Gordon
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.